Home

LIT에서는 뇌질환 치료제 및 항염증 치료제 분야에 관심있는 석박통합과정 지원생을 모집합니다. 열정적인 분들의 많은 연락 바랍니다.

Research Overview

Founded in 2006 under the leadership of Professor Sang-Kyung Lee, the Lab of Immunotherapeutics (LIT) focuses on advancing therapeutic approaches, such as Fas-signaling blockade and RNA interference (RNAi), to target apoptosis and inflammation in various diseases and develop innovative strategies for the targeted delivery of therapeutic agents.

Current Research Topics

Fas-Signaling Blocking Peptides for treating apoptosis-related diseases
siRNA-Based Therapeutics for immunological and inflammatory diseases
Intranasal Delivery Systems for non-invasive therapeutic applications

QUICK MENU

Recent Publications

Systemic Treatment with siRNA Targeting Gamma-Secretase Activating Protein Inhibits Amyloid-β Accumulation in Alzheimer’s Disease

Biomaterials Research (IF 8.1), DOI: 10.34133/bmr.0027, (Jun. 2024)

Blocking Fas-signaling in adipocytes and hepatocytes prevents obesity-associated inflammation, insulin resistance, and hepatosteatosis

J IND ENG CHEM (IF 5.9), https://doi.org/10.1016/j.jiec.2024.01.055, (Jan. 2024)

Systemic Treatment with Fas-Blocking Peptide Attenuates Apoptosis in Brain Ischemia

Int. J. Mol. Sci. (IF 5.6), https://doi.org/10.3390/ijms25010661, (Jan. 2024)

Report abuse

Systemic Treatment with siRNA Targeting Gamma-Secretase Activating Protein Inhibits Amyloid-β Accumulation in Alzheimer’s Disease

Blocking Fas-signaling in adipocytes and hepatocytes prevents obesity-associated inflammation, insulin resistance, and hepatosteatosis

Systemic Treatment with Fas-Blocking Peptide Attenuates Apoptosis in Brain Ischemia

RELATED SITES

QUICK LINK